Skip to main content
. 2021 Jul 13;14:3387–3396. doi: 10.2147/IJGM.S315505

Figure 3.

Figure 3

Rate of survival without luminal relapse in patients treated with nonbiological medications or infliximab using Kaplan-Meier analysis.